NASDAQ:XCUR - Nasdaq - US30205M3097 - Common Stock - Currency: USD
Top movers analysis in the middle of the day on 2025-01-23: top gainers and losers in today's session.
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
GPCR USA is noted for its work in developing cutting-edge treatments, including Opdivo, a widely used autoimmune disease therapy generating about $10 billion in annual revenue.
Wednesday's after hours session: top gainers and losers
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exicure (NASDAQ:XCUR) just reported results for the second quarter of 2024.Exic...
Exicure just reported results for the second quarter of 2024.